G6PD and ovarian carcinoma: Additionally, a study by Catanzaro et al. demonstrated that the inhibition of glucose-6-phosphate dehydrogenase could sensitise cisplatin-resistant ovarian cancer cells to cytotoxic death, further highlighting the role of the oxidative phosphorylation pathway in cisplatin resistance [51].